- FDA-Approved Irregular Heart Rhythm Feature Coming to Samsung Galaxy Watch Series 목차
Samsung Electronics has announced that their Galaxy Watch series will soon include an Irregular Heart Rhythm Notification (IHRN) feature. The feature, which is part of the Samsung Health Monitor app, has recently been granted approval by the US Food and Drug Administration (FDA)
The new IHRN function will come pre-installed on the upcoming Galaxy Watch 6, set for release in the latter half of the year. Existing Galaxy Watch 5 and Watch 4 series devices will also receive the feature through software updates. Utilizing the Bio Active Sensor in the Galaxy Watch, the IHRN function continuously monitors the wearer's heartbeat. If an irregular rhythm is detected, the watch will alert the user of a potential atrial fibrillation issue. Atrial fibrillation is a type of arrhythmia that can lead to blood clots, strokes, heart attacks, and other cardiac complications.
The IHRN function will also prompt users to utilize the built-in electrocardiogram (ECG) feature for a more accurate heart rate reading. Users can review their irregular heart rhythm history through the ECG monitoring function in the Samsung Health Monitor app.
Hon Pak, Vice President of Digital Health Team at Samsung Electronics MX Division, said, "The FDA-approved irregular heart rhythm notification function can be of great help to those who are not aware of heart-related risk situations." Samsung is committed to developing a range of monitoring technologies to protect users' health.